S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

NASDAQ:MASI - Masimo Stock Price, Forecast & News

$182.23
+0.74 (+0.41 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$178.46
Now: $182.23
$183.25
50-Day Range
$157.60
MA: $170.03
$183.96
52-Week Range
$118.93
Now: $182.23
$184.45
Volume942,647 shs
Average Volume374,535 shs
Market Capitalization$9.72 billion
P/E Ratio54.40
Dividend YieldN/A
Beta1.11
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:MASI
CUSIP57479510
Phone949-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$858.29 million
Cash Flow$3.57 per share
Book Value$18.29 per share

Profitability

Net Income$193.54 million

Miscellaneous

Employees1,500
Market Cap$9.72 billion
Next Earnings Date2/19/2020 (Confirmed)
OptionableOptionable

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.


Masimo (NASDAQ:MASI) Frequently Asked Questions

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) issued its earnings results on Wednesday, October, 30th. The medical equipment provider reported $0.76 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.73 by $0.03. The medical equipment provider had revenue of $229.01 million for the quarter, compared to analysts' expectations of $221.92 million. Masimo had a return on equity of 17.32% and a net margin of 20.83%. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.71 EPS. View Masimo's Earnings History.

When is Masimo's next earnings date?

Masimo is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Masimo.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY 2020 After-Hours earnings guidance on Wednesday, February, 19th. The company provided earnings per share (EPS) guidance of 3.56-3.56 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.55. The company issued revenue guidance of $1.035-1.035 billion, compared to the consensus revenue estimate of $1.03 billion.

What price target have analysts set for MASI?

6 brokerages have issued 1-year price targets for Masimo's stock. Their forecasts range from $134.50 to $190.00. On average, they expect Masimo's stock price to reach $167.08 in the next twelve months. This suggests that the stock has a possible downside of 8.3%. View Analyst Price Targets for Masimo.

What is the consensus analysts' recommendation for Masimo?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Masimo.

Has Masimo been receiving favorable news coverage?

News headlines about MASI stock have been trending somewhat positive on Wednesday, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Masimo earned a news sentiment score of 0.7 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Masimo.

Are investors shorting Masimo?

Masimo saw a decline in short interest during the month of January. As of January 31st, there was short interest totalling 999,000 shares, a decline of 34.7% from the January 15th total of 1,530,000 shares. Based on an average daily volume of 323,800 shares, the short-interest ratio is presently 3.1 days. Currently, 2.0% of the company's shares are short sold. View Masimo's Current Options Chain.

Who are some of Masimo's key competitors?

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Mastercard (MA), Paypal (PYPL), Shopify (SHOP), Twilio (TWLO), Trade Desk (TTD) and Visa (V).

Who are Masimo's key executives?

Masimo's management team includes the folowing people:
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 54)
  • Mr. Micah Young, Exec. VP of Fin. & CFO (Age 40)
  • Mr. Anand Sampath, Chief Operating Officer (Age 53)
  • Dr. Steven J. Barker, Chairman of Scientific Advisory Board, Chief Science Officer & Director (Age 74)
  • Mr. Thomas Samuel McClenahan, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)

Who are Masimo's major shareholders?

Masimo's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (8.82%), Citigroup Inc. (2.88%), Massachusetts Financial Services Co. MA (2.49%), State Street Corp (2.23%), Champlain Investment Partners LLC (2.00%) and Bank of New York Mellon Corp (1.86%). Company insiders that own Masimo stock include Anand Sampath, Bilal Muhsin, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.

Which institutional investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., AQR Capital Management LLC, Victory Capital Management Inc., Victory Capital Management Inc., First Trust Advisors LP, Renaissance Technologies LLC, Bank of New York Mellon Corp and Janus Henderson Group PLC. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Bilal Muhsin, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Insider Buying and Selling for Masimo.

Which institutional investors are buying Masimo stock?

MASI stock was acquired by a variety of institutional investors in the last quarter, including Citigroup Inc., FMR LLC, Massachusetts Financial Services Co. MA, Westfield Capital Management Co. LP, Bank of Montreal Can, Champlain Investment Partners LLC, TD Asset Management Inc. and UBS Group AG. View Insider Buying and Selling for Masimo.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $182.23.

How big of a company is Masimo?

Masimo has a market capitalization of $9.72 billion and generates $858.29 million in revenue each year. The medical equipment provider earns $193.54 million in net income (profit) each year or $3.03 on an earnings per share basis. Masimo employs 1,500 workers across the globe.View Additional Information About Masimo.

What is Masimo's official website?

The official website for Masimo is http://www.masimo.com/.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]


MarketBeat Community Rating for Masimo (NASDAQ MASI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  391 (Thanks for Voting!)
Underperform Votes:  388 (Thanks for Voting!)
Total Votes:  779
MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe MASI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MASI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel